The paraquat lawsuit continues to evolve, with new cases and legal decisions impacting those affected by the commercial-strength herbicide. This blog provides a detailed overview and the latest updates on significant developments in the litigation.
What is paraquat?
Paraquat dichloride, commonly referred to as paraquat, is one of the most commonly used herbicides in the United States. First introduced in 1964, and re-registered 1997, this chemical has long been used to control unwanted vegetation on farms. Due to its toxic nature, the Environmental Protection Agency (EPA) has classified paraquat as a “restricted use” herbicide, meaning only licensed farmers are permitted to purchase, handle, and apply it.
Who are the paraquat defendants?
The primary defendants in the ongoing paraquat cases are Syngenta and Chevron, Inc. A significant lawsuit involves a multidistrict litigation (MDL) targeting Gramoxone, a paraquat-based product developed by Syngenta and distributed in the U.S. by Chevron. The plaintiffs in this MDL claim that exposure to Gramoxone caused Parkinson’s disease in individuals who worked with or applied the herbicide.
What is the paraquat lawsuit?
A growing body of evidence has linked paraquat exposure to Parkinson’s disease, a neurodegenerative disorder that mainly affects the dopamine-producing neurons in a specific part of the brain. Individuals with Parkinson’s often experience symptoms such as tremors and limb stiffness, along with non-motor issues including depression, anxiety, and fatigue.
The paraquat lawsuit centers around the herbicide’s potential role in causing or contributing to Parkinson’s disease. Those who have been exposed to paraquat are at risk of developing these life-altering health conditions. The lawsuit aims to hold manufacturers accountable for the harm caused by exposure and seeks compensation for affected individuals.
Where is paraquat used?
Paraquat is primarily used on farms to kill grass, weeds, and other unwanted plant growth. Because of its hazardous properties, it can only be handled by licensed professionals. The EPA mandates that those who work with paraquat must follow strict guidelines to reduce the risk of exposure. Despite these precautions, paraquat remains a significant concern due to its impact on human health. A single sip can be fatal and there is no known antidote.
What are common forms of exposure to paraquat?
Exposure to paraquat can occur in several ways, including:
- Swallowing
- Skin contact
- Inhaling vapors
- Ingesting contaminated food and drink
- Herbicide drift, overspray, or runoff
The widespread application of paraquat has sparked growing concerns, particularly in rural areas where its use is more prevalent. People living near industrial farms, children attending schools in rural areas, and even golfers playing on courses treated with paraquat may have been unknowingly exposed to the herbicide.
What are common herbicides that contain paraquat?
Several herbicides on the market contain paraquat as a key ingredient. These include popular products such as:
- Gramoxone
- Blanco
- Devour
- Firestorm
- Helmquat
- Para-Shot 30
- Parazone
- Tota-col
What are the most recent updates in the paraquat lawsuit?
September 2024: Syngenta Loses PA Jurisdiction Fight, Faces Ruling on Insurance Coverage
Syngenta filed a motion in a Philadelphia state court, arguing that the majority of plaintiffs in the paraquat lawsuits are not from Pennsylvania and therefore should not be allowed to file there. At the heart of the issue is Pennsylvania’s “consent by registration” statute, which allows companies registered to do business in the state to be sued there, even by out-of-state plaintiffs. Syngenta claimed this law could be unconstitutional, despite a recent Supreme Court ruling upholding it. The Pennsylvania Superior Court rejected Syngenta’s argument, a win for plaintiffs’ attorneys who are now preparing for the first paraquat trial scheduled for April.
A Delaware judge has also ordered two companies involved in paraquat lawsuits, including Syngenta, to release certain legal documents related to the cases. However, only those that exclude legal advice from their law firm need to be provided. The companies are in litigation with insurers, such as Hartford and Travelers, over defense cost coverage. The insurers had requested access to documents tied to the Paraquat lawsuits, but Syngenta initially withheld them, citing attorney-client privilege. This ruling is significant since the more insurance coverage available, the greater the potential for a favorable settlement.
More than 50 new cases were filed in the Paraquat class action MDL last month, pushing the total number of active cases to 5,891.
August 2024: New Bellwether Cases and Ongoing Legal Actions
The paraquat Multidistrict Litigation (MDL) continues to evolve with significant recent updates. MDL Judge Rosenstengel selected 10 new bellwether cases set to begin in 2025, following the dismissal of the first four bellwether cases due to the exclusion of a key plaintiff expert. The Plaintiffs’ Committee provided a status update, highlighting the selection of these new plaintiffs and ongoing case-specific discovery efforts.
In Delaware, defendants’ motions to dismiss were partially granted, requiring amended pleadings from the plaintiffs to proceed. Additionally, a new lawsuit was filed by a man from Washington, claiming that his prolonged exposure to paraquat caused him to develop Parkinson’s disease. Diagnosed with Parkinson’s in 2013, the plaintiff claims he was exposed to paraquat between 1966 and 1975 while working at a fish hatchery in Washington. His lawsuit alleges that paraquat was applied near his workplace using ground-based or aerial sprayers.
July 2024: Lawsuit Dismissals, New Filings, and Subpoena Quashing
In July, a federal judge in Texas quashed a subpoena from paraquat plaintiffs seeking discovery from Texas state agencies, citing the principle of “sovereign immunity.” Meanwhile, three new lawsuits were filed in the MDL, including one by a Pennsylvania farmer who alleges that paraquat exposure from 1976 to 1996 was the cause of his Parkinson’s disease.
Another notable development was the dismissal of 74 paraquat lawsuits within the MDL, signaling that discussions around a potential global settlement may be gaining traction. The first trial in Philadelphia state court is scheduled for April 2025, but many expect settlements before the trial begins. Additionally, three more trials are set to commence in the Philadelphia Court of Common Pleas that same month.
The MDL saw a slight uptick in active cases in July, increasing from 5,680 to 5,770.
What You Can Do
By working with Broughton Partners, law firms gain more clients and build better connections between claimants, litigating firms, and referring firms. With various consumer-facing brands, we reach out to potential claimants across television, radio, social media, and other advertising avenues. Claimants contact our in-house 24/7 call center and are screened for eligibility using criteria created with leading litigators. These pre-qualified retainers are then delivered to your firm without any additional work on your part.
Our process lets attorneys help more people without adding to their workload and gives claimants more power to find necessary legal aid. Ready to learn more? Call us at (844) 206-4644 or complete our online contact form today.